GE HealthCare Technologies Inc, the General Electric (NYSE:GE) spinoff, beat first-quarter earnings and revenue expectations in its second quarter as a standalone company.
That hasn’t stopped the medical device company’s stock from dropping more than 8% Tuesday morning to $80.14. The reason for the decline is likely a bit of profit-taking from investors — the stock has gained 50% since the beginning of 2023.
The Chicago-based company reported revenue of $4.7 billion, up 8% year-over-year and ahead of Street expectations of $4.6 billion, and earnings of $0.85 per share, similarly topping expectations of $0.79.
“We saw strong revenue growth across all of our business segments and regions as supply chain challenges eased,” CEO Peter Arduini said in a statement.
GE HealthCare left its full-year adjusted EPS projection of $3.60 to $3.75 unchanged.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel